Global contract development and manufacturing organization for radiotherapeutics.
Location: Canada, Ontario, Hamilton
Total raised: $90M
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.06.2023 | - | $90M | - |
Mentions in press and media 6
| Date | Title | Description |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON, June 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A ... |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON /CNW/ – AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its c... |
| 01.03.2023 | AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario | TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facilit... |
| 25.08.2022 | AtomVie Global Radiopharma Closes Series A Financing with Avego | AtomVie Global Radiopharma, an Hamilton, ON, Canada-based Contract Development and Manufacturing Organization for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals, raised an undisclosed amount in Series... |
| 24.08.2022 | AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego | HAMILTON ON, Aug. 24, 2022 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. ... |
| - | AtomVie Global Radiopharma | “AtomVie | Global Radiopharma” |